We can’t show the full text here under this license.
Alternate-day fasting may reduce protein buildup and inflammation through the gut-brain connection in a mouse model of Parkinson’s disease
Updated
Abstract
Essence
Alternate-day fasting reduced Parkinson-like α-synuclein pathology and inflammation in a mouse model, with gut microbiota implicated in the effect.
Evidence
This MPTP-induced subacute mouse study found optimal neuroprotection after 16 weeks of ADF and similar protection after fecal microbiota transplantation from ADF mice.
Caveat
The findings come from a mouse model with microbiota-transfer experiments, so they do not establish clinical benefit in human Parkinson's disease.
Simplified
Key numbers
16 weeks
Decrease in α-synuclein Levels
Optimal duration of to achieve neuroprotective effects in PD mice.
+
Fecal Microbiota Transplantation Effectiveness
FMT from mice alleviates neurotoxicity in PD models.